medigraphic.com
ISSN 0185-3325 (Impreso)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2023, Número 5

<< Anterior Siguiente >>

Salud Mental 2023; 46 (5)


Ethical and social issues in research on genetics and mental health

Rodríguez-Yunta E

Idioma: Ingles.
Referencias bibliográficas: 89
Paginas: 251-259
Archivo PDF: 210.11 Kb.


RESUMEN

Objetivo. Este artículo reflexiona sobre temas éticos y sociales de investigación genética en salud mental. Método. Se realizó revisión narrativa mediante búsqueda en bases de datos: Medline, Scopus and Scielo (se revisaron 87 artículos). Las palabras claves se definieron con amplitud para mayor número de publicaciones relevantes. Los datos fueron resumidos de acuerdo con el tema. Resultados. Se identificaron los siguientes temas en la aplicación de herramientas genéticas y genómicas en trastornos de salud mental: problemas de diagnóstico, procedimientos de consentimiento informado apropiados, protección de confidencialidad, información a participantes de resultados, balance de riesgos y beneficios, equidad y acceso, comercialización de genotipos y pruebas prenatales. Discusión y conclusión. A pesar de promesas, todavía debe realizarse mucha investigación genética en salud mental para lograr relevancia clínica y valor predictivo, con mayor deficiencia en países en desarrollo. Los estudios de costo-beneficio no recomiendan realizar diagnóstico genético para enfermedades mentales cuando existen pocos datos. Se necesita mejorar soluciones locales para abordar la salud mental. Una limitación es que la genética busca causas biológicas, pero la etiología de muchos trastornos mentales es multifactorial, disminuyendo el valor predictivo de pruebas genéticas. Sin embargo, encontrar el origen genético de caminos biológicos que conducen a enfermedad mental es muy importante para diagnóstico y terapia. Otros problemas consisten en encontrar métodos para mejorar el proceso de consentimiento informado y asesoría genética, la discusión si se debe preservar el derecho a saber o el derecho a no saber y el cómo la genetización de la enfermedad mental se relaciona con estigma.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Abacan, M., Alsubaie, L., Barlow-Stewart, K., Caanen, B., Cordier, C., Coutney, E.,… Wicklund, C. (2019). The Global State of the Genetic Counseling Profession.European Journal of Human Genetics, 27(2), 183-197. doi: 10.1038/s41431-018-0252-x

  2. Akingbuwa, W. A., Hammerschlag, A. R., Bartels, M., & Middeldorp, C. M. (2022).Systematic Review: Molecular Studies of Common Genetic Variation in Childand Adolescent Psychiatric Disorders. Journal of the American Academy ofChild & Adolescent Psychiatry, 61(2), 227-242. doi: 10.1016/j.jaac.2021.03.020

  3. Andorno, R. (2004). The right not to know: an autonomy based approach. Journal ofMedical Ethics, 30(5), 435-439. doi: 10.1136/jme.2002.001578

  4. Arribas-Ayllon, M. (2016). After geneticization. Social Science & Medicine, 159,132-139. doi: 10.1016/j.socscimed.2016.05.011

  5. Arribas-Ayllon, M., Sarangi, S., & Clarke, A. (2009). Professional Ambivalence:Accounts of Ethical Practice in Childhood Genetic Testing. Journal of GeneticCounseling, 18(2), 173-184. doi: 10.1007/s10897-008-9201-0

  6. Atutornu, J., Milne, R., Costa, A., Patch, C., & Middleton, A. (2022). Towardsequitable and trustworthy genomics research. EBioMedicine, 76, 103879. doi:10.1016/j.ebiom.2022.103879

  7. Austin, J. C. (2020). Evidence-Based Genetic Counseling for Psychiatric Disorders:A Road Map. Cold Spring Harbor Perspectives in Medicine, 10(6), a036608.doi: 10.1101/cshperspect.a036608

  8. Barney, L., Griffiths, K. M., Christensen, H., & Jorm, A. (2009). Exploring the natureof stigmatising beliefs about depression and help-seeking: implications forreducing stigma. BMC Public Health, 9, 61 doi: 10.1186/1471-2458-9-61

  9. Bemelmans, S, A., Tromp, K., Bunnik, E. M., Milne, R. J., Badger, S., Brayne, C.,... Richard, E. (2016). Psychological, behavioral and social effects of disclosingAlzheimer’s disease biomarkers to research participants: a systematic review.Alzheimer’s Research & Therapy, 8(1), 46. doi: 10.1186/s13195-016-0212-z

  10. Bennett, L., Thirlaway, K., & Murray, A. J. (2008). The stigmatising implications ofpresenting schizophrenia as a genetic disease. Journal of Genetic Counseling,17(6), 550-559. doi: 10.1007/s10897-008-9178-8

  11. Bhugra, D., Tribe, R., & Poulter, D. (2022). Social justice, health equity, andmental health. South African Journal of Psychology, 52(1), 3-10. doi:10.1177/00812463211070921

  12. Bortolotti, L., & Widdows, H. (2011). The right not to know: the case of psychiatricdisorders. Journal of Medical Ethics, 37(11), 673-676. doi: 10.1136/jme.2010.041111

  13. Bray, N. J., & O’Donovan, M. C. (2018). The genetics of neuropsychiatricdisorders. Brain and Neuroscience Advances, 2, 2398212818799271. doi:10.1177/2398212818799271

  14. Broberg, G., & Roll-Hansen, N. (Eds.). (2005). Eugenics and the Welfare State:Norway, Sweden, Denmark, and Finland. Michigan State University Press.ISBN 978-0870137587

  15. Chipman, P. (2006). The moral implications of prenatal genetic testing. PennBioethics Journal, 2(2), 13-16.

  16. Clarke, D., Dusome, D., & Hughes, L. (2007). Emergency department from themental health client’s perspective. International Journal of Mental HealthNursing, 16(2), 126-131. doi: 10.1111/j.1447-0349.2007.00455.x

  17. Cummings, J. R., Lucas, S. M., & Druss, B. G. (2013). Addressing Public Stigmaand Disparities Among Persons With Mental Illness: The Role of FederalPolicy. American Journal of Public Health, 103(5), 781-785. doi: 10.2105/AJPH.2013.301224

  18. Cuthbert, B. N., & Insel, T. R. (2013). Toward the future of psychiatric diagnosis: theseven pillars of RDoC. BMC Medicine, 11, 126. doi: 10.1186/1741-7015-11-126

  19. de Vries, J., Landouré, G., & Wonkam, A. (2020). Stigma in African genomicsresearch: Gendered blame, polygamy, ancestry and disease causal beliefs impacton the risk of harm. Social Science & Medicine, 258, 113091. doi: 10.1016/j.socscimed.2020.113091

  20. Demkow, U., & Wolańczyk, T. (2017). Genetic tests in major psychiatric disordersintegratingmolecular medicine with clinical psychiatry-why is it so difficult?Translational Psychiatry, 7(6), e1151. doi: 10.1038/tp.2017.106

  21. Dunn, L. B., & Misra, S. (2009). Research ethics issues in geriatric psychiatry.Psychiatric Clinics of North America, 32(2), 395-411. doi: 10.1016/j.psc.2009.03.007

  22. Dunn, L. B., Nowrangi, M. A., Palmer, B. W., Jeste, D. V., & Saks, E. R. (2006).Assessing decisional capacity for clinical research or treatment: areview ofinstruments. American Journal of Psychiatry, 163(8), 1323-1334. doi: 10.1176/ajp.2006.163.8.1323

  23. Evans, L. (1980). Psychological effects caused by drugs in overdose. Drugs, 19(3),220-242. doi: 10.2165/00003495-198019030-00005

  24. Finucane, B. M., Ledbetter, D. H., & Vorstman, J. A. (2021). Diagnostic genetictesting for neurodevelopmental psychiatric disorders: closing the gap betweenrecommendation and clinical implementation. Current Opinion in Genetics &Development, 68, 1-8. doi: 10.1016/j.gde.2020.12.016

  25. Frebourg, T. (2014). The challenge for the next generation of medical geneticists.Human Mutation, 35(8), 909-911. doi: 10.1002/humu.22592

  26. Galton, F. (1901). The Possible Improvement of the Human Breed Under the ExistingConditions of Law and Sentiment. Nature, 64, 659-665. doi: 10.1038/064659b0

  27. Gejman, P. V., Sanders, A. R., & Kendler, K. S. (2011). Genetics of schizophrenia:new findings and challenges. Annual Review of Genomics and Human Genetics,12, 121-144. doi: 10.1146/annurev-genom-082410-101459

  28. Geschwind, D. H., & Flint, J. (2015). Genetics and genomics of psychiatric disease.Science, 349(6255), 1489-1494. doi: 10.1126/science.aaa8954

  29. Hamilton, S., Pinfold, V., Cotney, J., Couperthwaite, L., Matthews, J., Barret, K.,... Henderson, C. (2016). Qualitative analysis of mental health service users’reported experiences of discrimination. Acta Psychiatrica Scandinavica,134(Suppl 446), 14-22. doi: 10.1111/acps.12611

  30. Harmon, A. (2010) Indian tribe wins fight to limit research of its DNA. New YorkTimes, April 21 (p. 1).

  31. Hartvigsson, T. (2023). Between Punishment and Care: Autonomous Offenders WhoCommit Crimes Under the Influence of Mental Disorder. Criminal Law andPhilosophy, 17, 111-134. doi: 10.1007/s11572-021-09595-4

  32. Hiriscau, E. I., Stingelin-Giles, N., Wasserman, D., & Reiter-Theil, S. (2016).Identifying Ethical Issues in Mental Health Research with Minors Adolescents:Results of a Delphi Study. International Journal of Environmental Researchand Public Health, 13(5), 489. doi: 10.3390/ijerph13050489

  33. Hoop, J. G. (2008). Ethical considerations in psychiatric genetics. Harvard Review ofPsychiatry, 16(6), 322-338. doi: 10.1080/10673220802576859

  34. Hughes, K., Lowey, H., Quigg, Z., & Bellis, M. A. (2016). Relationships betweenadverse childhood experiences and adult mental well-being: results from anEnglish national household survey. BMC Public Health, 16, 222. doi: 10.1186/s12889-016-2906-3

  35. Humphrey, N., & Hebron, J. (2015). Bullying of children and adolescents withautism spectrum conditions: a ‘state of the field’ review. International Journalof Inclusive Education, 19(8), 845-862. doi: 10.1080/13603116.2014.981602

  36. Husky, M. M., Delbasty, E., Bitfoi, A., Carta, M. G., Goelitz, D., Koç, C., ... Kovess-Masfety, V. (2020). Bullying involvement and self-reported mental health inelementary school children across Europe. Child Abuse & Neglect, 107, 104601.doi: 10.1016/j.chiabu.2020.104601

  37. Ienca, M., Ferretti, A., Hurst, S., Puhan, M., Lovis, C., & Vayena, E. (2018).Considerations for ethics review of big data health research: A scoping review.PLoS One, 13(10), e0204937. doi: 10.1371/journal.pone.0204937

  38. Insel, T. R., & Collins, F. S. (2003). Psychiatry in the genomics era [Editorial].The American Journal of Psychiatry, 160(4), 616-620. doi: 10.1176/appi.ajp.160.4.616

  39. Jeste, D. V., Palmer, B. W., Golshan, S., Eyler, L. T., Dunn, L. B., Meeks, T., ...Appelbaum, P. S. (2009). Multimedia consent for research in people withschizophrenia and normal subjects: a randomized controlled trial. SchizophreniaBulletin, 35(4), 719-729. doi: 10.1093/schbul/sbm148

  40. Kamaara, E., Kong, C., & Campbell, M. (2020). Prioritising African perspectivesin Psychiatric Genomics Research: issues of translation and informed consent.Developing World Bioethics, 20(3), 139-149. Retrieved from https://eprints.bbk.ac.uk/id/eprint/29339/

  41. Karlawish, J. H., Knopman, D., Clark, C. M., Morris, J. C., Marson, D., Whitehouse,P. J., & Kawas, C. H. (2002). Informed consent for Alzheimer’s disease clinicaltrials: a survey of clinical investigators. Institutional Review Board Journal,24(5), 1-5.

  42. Kelly, B. D. (2017). Confidentiality and privacy in the setting of involuntary mentalhealth care: What standards should apply? Ethics, Medicine and Public Health,3(1), 90-97. doi: 10.1016/j.jemep.2017.02.020

  43. Kious, B. M., Docherty, A. R., Botkin, J. R., Brown, T. R., Francis, L. P., Gray, D.D., ... Coon, H. (2021). Ethical and public health implications of genetic testingfor suicide risk: family and survivor perspectives. Genetics in Medicine, 23(2),289-297. doi: 10.1038/s41436-020-00982-1

  44. Knaak, S., Mantler, E., & Szeto, A. (2017). Mental illness-related stigma inhealthcare: Barriers to access and care and evidence-based solutions. HealthcareManagement Forum, 30(2), 111-116. doi: 10.1177/0840470416679413

  45. Knifton, L., & Inglis, G. (2020). Poverty and mental health: policy, practice andresearch implications. BJPsych Bulletin, 44(5), 193-196. doi: 10.1192/bjb.2020.78

  46. Knoppers, B. M., & Chadwick, R. (2005) Human genetic research: emerging trendsin ethics. Nature Reviews Genetics, 6(1), 75-79. doi: 10.1038/nrg1505

  47. Knoppers, B. M., Avard, D., Cardinal, G., & Glass, K. C. (2002). Science and society:children and incompetent adults in genetic research: consent and safeguards.Nature Reviews Genetics, 3(3), 221-225. doi: 10.1038/nrg750

  48. Kose, S., & Cetin, M. (2018). Psychiatric pharmacogenomics in the age of neuroscience:promises and challenges. Psychiatry and Clinical Psychopharmacology, 28(3),231-235. doi: 10.1080/24750573.2018.1518191

  49. Kostick, K., Pereira, S., Brannan, C., Torgerson, L., & Lázaro-Muñoz, G. (2020).Psychiatric genomics researchers’ perspectives on best practices for returningresults to individual participants. Genetics in Medicine, 22(2), 345-352. doi:10.1038/s41436-019-0642-7

  50. Kutz, G. (2010). Direct-to-consumer genetic tests: misleading test results are furthercomplicated by deceptive marketing and other questionable practices, Rep.GAO-10-847T. Washington, DC: US Government Publishing Office. Retrievedfrom http://www.gao.gov/products/GAO-10-847T50. Lebowitz, M. S., & Ahn, W.-K. (2014). Effects of biological explanations for mentaldisorders on clinicians’ empathy. Proceedings National Academy of Science,111(50), 17786-17790.doi: 10.1073/pnas.1414058111

  51. Lee, A. A., Laurent, S. M., Wykes, T. L., Kitchen Andren, K. A., Bourassa, K. A.,& McKibbin, C. L. (2014). Genetic attributions and mental illness diagnosis:effects on perceptions of danger, social distance, and real helping decisions.Social Psychiatry and Psychiatric Epidemiology, 49(5), 781-789. doi: 10.1007/s00127-013-0764-1

  52. LeVine, E. S. (2012). Facilitating recovery for people with serious mental illnessemploying a psychobiosocial model of care. Professional Psychology: Researchand Practice, 43(1), 58-64. doi: 10.1037/a0026889

  53. Link, B. G., & Phelan, J. C. (2001) Conceptualizing stigma. Annual Review ofSociology, 27(1), 363-385. doi: 10.1146/annurev.soc.27.1.363

  54. Marson, D. C., Ingram, K. K., Cody, H. A., & Harrell, L. E. (1995). Assessing thecompetency of patients with Alzheimer’s disease under different legal standards.A prototype instrument. Archives of Neurology, 52(10), 949-954. doi: 10.1001/archneur.1995.00540340029010

  55. McGuire, A. L., & Beskow, L. M. (2010). Informed consent in genomics and geneticresearch. Annual Review of Genomics and Human Genetics, 11, 361-381. doi:10.1146/annurev-genom-082509-141711

  56. Meiser, B., & Dunn, S. (2000). Psychological impact of genetic testing forHuntington’s disease: an update of the literature. Journal of Neurology,Neurosurgery & Psychiatry, 69(5), 574-578. doi: 10.1136/jnnp.69.5.574

  57. Mezinska, S., Gallagher, L., Verbrugge, M., & Bunnik, E. M. (2021). Ethical issuesin genomics research on neurodevelopmental disorders: a critical interpretivereview. Human Genomics, 15(1), 16. doi: 10.1186/s40246-021-00317-4

  58. Moser, D. J., Reese, R. L., Hey, C. T., Schultz, S. K., Arndt, S., Beglinger, L. J.,... Andreasen, N. C. (2006), Using a brief intervention to improve decisionalcapacity in schizophrenia research. Schizophrenia Bulletin, 32(1), 116-120. doi:10.1093/schbul/sbi066

  59. Nelson, C. A., Bhutta, Z. A., Burke Harris, N., Danese, A., & Samara, M. (2020).Adversity in childhood is linked to mental and physical health throughout life.British Medical Journal, 371, m3048. doi: 10.1136/bmj.m3048

  60. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium.(2015). Psychiatric genome-wide association study analyses implicate neuronal,immune and histone pathways. Nature Neuroscience, 18(2), 199-209. doi:10.1038/nn.3922

  61. Nuffield Council. (1998). Mental disorders and genetics: the ethical context. NuffieldCouncil on Bioethics. Retrieved from https://www.nuffieldbioethics.org/publications/mental-disorders-and-genetics

  62. Nyblade, L., Stockton, M. A., Giger, K., Bond, V., Ekstrand, M. L., Lean R. M., ...Wouters, E. (2019). Stigma in health facilities: why it matters and how we canchange it. BMC Medicine, 17(1), 25. doi: 10.1186/s12916-019-1256-2

  63. Ortiz-Hernández, L., López-Moreno, S., & Borges, G. (2007). Desigualdadsocioeconómica y salud mental: revisión de la literatura latinoamericana.Cadernos de Saúde Pública, 23(6), 1255-1272. Retrieved from https://www.scielo.br/j/csp/a/FfRpzWkf5jXF9cvHY63qQ6D/?lang=es#

  64. Palmer, B. W., Cassidy, E. L., Dunn, L. B., Spira, A. P., & Sheikh, J. I. (2008).Effective use of consent forms and interactive questions in the consent process.Institutional Review Board Journal, 30(2), 8-12.

  65. Palmer, B. W., Savla, G. N., Roesch, S. C., & Jeste, D. V. (2013). Changes in capacityto consent over time in patients involved in psychiatric research. British Journalof Psychiatry, 202(6), 454-458. doi: 10.1192/bjp.bp.112.121160

  66. Parens, E., & Appelbaum, P. (2019). Looking for the Psychosocial Impacts ofGenomic Information. Hastings Center Special Report, 49(Suppl S1), S2-S9.

  67. Parker, M., & Lucassen, A. M. (2004). Genetic information: a joint account? BritishMedical Journal, 329(7458), 165-167. doi: 10.1136/bmj.329.7458.165

  68. Peñaranda, F. (2013). Salud pública y justicia social en el marco del debate determinantes- determinación social de la salud. Revista Facultad Nacional de SaludPública, 31(Suppl. 1), 91-102. Retrieved from http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-386X2013000400011&lng=en&tlng=es

  69. Phelan, J. C. (2002). Genetic bases of mental illness—a cure for stigma? Trends inNeuroscience, 25(8), 430-431. doi: 10.1016/s0166-2236(02)02209-9

  70. Rodrigues, M. V. (2020). Genomics, Big Data and Privacy: Reflections upon theimplications of direct-to-consumer genetic testing. Natureza Humana, 22(1),50-70. doi: 10.17648/2175-2834-v22n1-432

  71. Rüsch, N., Angermeyer, M., & Corrigan, P. (2005). Mental illness stigma: Concepts,consequences, and initiatives to reduce stigma. European Psychiatry, 20(8),529-539. doi: 10.1016/j.eurpsy.2005.04.004

  72. Saxena, S., Thornicroft, G., Knapp, M., & Whiteford, H. (2007). Resources formental health: scarcity, inequity, and inefficiency. Lancet, 370(9590), 878-889.doi: 10.1016/S0140-6736(07)61239-2

  73. Schomerus, G., Matschinger, H., & Angermeyer, M. C. (2014). Causal beliefs ofthe public and social acceptance of persons with mental illness: a comparativeanalysis of schizophrenia, depression and alcohol dependence. PsychologicalMedicine, 44(2), 303-314. doi: 10.1017/S003329171300072X

  74. Schulte-Körne, G. (2016). Mental Health Problems in a School Setting in Childrenand Adolescents. Deutsches Ärzteblatt International, 113(11), 183-190. doi:10.3238/arztebl.2016.0183

  75. Semaka, A., & Austin, J. (2019). Patient perspectives on the process and outcomesof psychiatric genetic counseling: An “Empowering Encounter”. Journal ofGenetic Counseling, 28(4), 856-868. doi: 10.1002/jgc4.1128

  76. Sharac, J., Mccrone, P., Clement, S., & Thornicroft, G. (2010). The economic impactof mental health stigma and discrimination: A systematic review. Epidemiologiae Psichiatria Sociale, 19(3), 223-232. doi: 10.1017/S1121189X00001159

  77. Shore, D., Berg, K., Wynne, D., & Folstein, M. F. (1993). Legal and ethical issuesin psychiatric genetic research. American Journal of Medical Genetics, 48(1),17-21. doi: 10.1002/ajmg.1320480106

  78. Smikowski, J., Dewane, S., Johnson, M. E., Brems, C., Bruss, C., & Roberts, L.W.(2009). Community-Based Participatory Research for Improved Mental Health.Ethics & Behavior, 19(6), 461-478. doi: 10.1080/10508420903274971

  79. Sullivan, P. F., Agrawal, A., Bulik, C. M., Andreassen, O. A., Børglum, A. D., Breen,G., ... O’Donovan, M. C., Psychiatric Genomics Consortium. (2018). PsychiatricGenomics: An Update and an Agenda. American Journal of Psychiatry, 175(1),15-27. doi: 10.1176/appi.ajp.2017.17030283

  80. Thornicroft, G., Rose, D., & Mehta, N. (2010). Discrimination against people withmental illness: what can psychiatrists do? Advances in Psychiatric Treatment,16(1), 53-59. doi: 10.1192/apt.bp.107.004481

  81. van Draanen, J., Tsang, C., Mitra, S., Phuong, V., Murakami, A., Karamouzian, M.,& Richardson, L. (2022). Mental disorder and opioid overdose: a systematicreview. Social Psychiatry and Psychiatric Epidemiology, 57(4), 647-671. doi:10.1007/s00127-021-02199-2

  82. Vears, D. F., Minion, J. T., Roberts, S. J., Cummings, J., Machirori, M., Blell, M.,... Murtagh, M. J. (2021). Return of individual research results from genomicresearch: A systematic review of stakeholder perspectives. PLoS One, 16(11),e0258646. doi: 10.1371/journal.pone.0258646

  83. Venkatapuram, S. (2010). Global Justice and the Social Determinants of Health. Ethics& International Affairs, 24(2), 119-130. doi: 10.1111/j.1747-7093.2010.00252.x

  84. Wade, C. H. (2019). What Is the Psychosocial Impact of Providing Genetic andGenomic Health Information to Individuals? An Overview of SystematicReviews. Hastings Center Report, 49(Suppl 1), S88-S96. doi: 10.1002/hast.1021

  85. Werner-Lin, A., Mccoyd, J. L. M., & Bernhardt, B. A. (2019). Actions andUncertainty: How Prenatally Diagnosed Variants of Uncertain SignificanceBecome Actionable. Hastings Center Report, 49(Suppl 1), S61-S71. doi:10.1002/hast.1018

  86. Westermann, S., Cavelti, M., Heibach, E., & Caspar, F. (2015). Motive-orientedtherapeutic relationship building for patients diagnosed with schizophrenia.Frontiers in Psychology, 6, 1294. doi: 10.3389/fpsyg.2015.01294

  87. World Health Organization [WHO]. (2019). The WHO special initiative for mentalhealth ( 2019-2023) : universal health coverage for mental health. World HealthOrganization. Retrieved from https://apps.who.int/iris/handle/10665/310981

  88. World Health Organization [WHO]. (2021). Health equity and its determinants.Geneva: World Health Organization. Retrieved from https://www.who.int/publications/m/item/health-equity-and-its-determinants

  89. Zipkin, D. A., Umscheid, C. A., Keating, N. L., Allen, E., Aung, K., Beyth, R., ...Feldstein, D. A. (2014). Evidence-based risk communication: a systematicreview. Annals of Internal Medicine, 161(4), 270-280. doi: 10.7326/M14-0295




2020     |     www.medigraphic.com